Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Daniel R. Barnes(University of Cambridge), Volker Arndt(German Cancer Research Center), Karoline Kuchenbaecker(University of Cambridge), Xia Jiang(Xuzhou Medical College), Hilary K. Finucane(Broad Institute), Julian Adlard(Chapel Allerton Hospital), Shahana Ahmed(University of Cambridge), Christopher I. Amos(The University of Texas MD Anderson Cancer Center), Joe Dennis(University of Cambridge), Bernd Auber(Medizinische Hochschule Hannover), Jacopo Azzollini(Fondazione IRCCS Istituto Nazionale dei Tumori), Fares Al‐Ejeh(QIMR Berghofer Medical Research Institute), Christine B. Ambrosone(Unknown), Roger L. Milne(The University of Melbourne), Margreet G.E.M. Ausems(McGill University Health Centre), Jamie Allen(University of Cambridge), Cora M. Aalfs(University of Amsterdam), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Laure Barjhoux(Centre Léon Bérard), Myrto Barrdahl(German Cancer Research Center), Irene L. Andrulis(University of Toronto), Paul L. Auer(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Norbert Arnold(Christian-Albrechts-Universität zu Kiel), Shirley Hui(Bronx-Lebanon Hospital Center), Rósa B. Barkardóttir(University of Iceland), Siddhartha Kar(University of Cambridge), Hoda Anton‐Culver(University of California, Irvine), Asha Rostamianfar(Johns Hopkins University), Judith Balmañà(Vall d'Hebron Hospital Universitari), Audrey Lemaçon(University of Cambridge), Kristan J. Aronson(Queen's University), Qin Wang(University of Cambridge), Simona Agata(Roswell Park Comprehensive Cancer Center), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Monica Barile(European Institute of Oncology), Kristiina Aittomäki(University of Helsinki), Lesley McGuffog(University of Cambridge), Sara Lindström(Harvard University), Marcia Adams(Broad Institute), Penny Soucy(University of Cambridge), Manjeet K. Bolla(University of Cambridge), François Bacot(The Netherlands Cancer Institute), Habibul Ahsan(Chicago Department of Public Health), Jonathan Beesley(QIMR Berghofer Medical Research Institute)
Cited by 476
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Detecting Novel Associations in Large Data Sets
|Science|2011|3.4k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k